P264 Medication usage in hypermobile ehlers-danlos syndrome/hypermobile spectrum disorder patients with concomitant disorders of gut-brain interactions

多药 医学 相伴的 内科学 儿科
作者
Advait Upadhyaya,Rabia Topan,Shraya Pandya,Sarah Williams,Natalia Zárate-López,Qasim Aziz,Chris Roukas,Borislava Mihaylova,Asma Fikree
出处
期刊: 卷期号:: A189.2-A190 被引量:1
标识
DOI:10.1136/gutjnl-2023-bsg.332
摘要

Introduction

Disorders of Gut-Brain Interactions (DGBI) are common in patients with Hypermobile Ehlers-Danlos Syndrome/Hypermobile Spectrum Disorder (hEDS/HSD). DGBIs are often difficult to manage, with polypharmacy worsening symptoms1 and contributing to increased healthcare costs. No study to date has looked at medication use and costs in patients with DGBI and coexistent hEDS/HSD.

Methods

A cross-sectional study was performed in hEDS/HSD patients from EDS-UK and tertiary neurogastroenterology clinics. Patients completed a ROME IV and healthcare utilisation questionnaire (adapted from the IBD Boost Study2) to include comorbidities and medications prescribed over 6 months. Costs were calculated based on the NHS Business Services Authority Prescription Cost Analysis.3

Results

660 hEDS/HSD patients completed the study; 92.9% were female, median age of 39. All fulfilled ROME IV criteria for ≥1 DGBI; there was a median of 6 other co-morbidities (table 1). Polypharmacy was very common. Patients were on a median of 6 medications (maximum 23) over 6 months, which accounted for 12% of total healthcare costs. 99.4% were on ≥1, 73.2% were on ≥5, 34.8% were on ≥8, and 3.3% were on ≥15 medications. Anticholinergics (e.g. buscopan, cyclizine) were the most commonly prescribed (75.5%) and costliest medications (£105.33 per patient over 6 months) followed by neuromodulators and antihistamines/mast cell stabilisers (MCS) (table 1). of the 47.4% on an antihistamine and/or MCS, 39.3% of patients were diagnosed with mast cell activation syndrome (MCAS). 39.4% were prescribed opioids. Patients were on a maximum of 4 opioids, with 21.8% on >1, and 14 (2.1%) on >3 opioids. A minority (n=11) of patients were on a non-oral opioid formulation (i.e. patch, lozenge or lolly). 23.6% were on an anti-emetic; of this 9.0% were on ≥3.

Conclusions

Despite their significant gastrointestinal side effects, opioids and anticholinergic medication were widely used in this cohort. Polypharmacy within as well as across drug classes, is highly prevalent, with the pharmaceutical burden more pronounced than in the elderly population.4 With significant costs and negative health outcomes associated with polypharmacy, practices should be reviewed, and guidelines created regarding prescribing and indeed deprescribing in this group of patients.

References

Maher, et al. Expert Opinion on Drug Safety. 2014;13(1). Roukas, et al. Frontline Gastroenterology 2022;14(1). NHSBSA. Prescription Cost Analysis – England 2020/21 2021. NHS Digital Health Survey for England – 2016.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Serendipity发布了新的文献求助10
1秒前
汤圆发布了新的文献求助10
2秒前
海鲸发布了新的文献求助20
2秒前
在望的应助被肖馨余采纳,获得10
2秒前
爱撒娇的朋友完成签到,获得积分10
3秒前
烟花的应助被flash采纳,获得10
4秒前
积极亦竹发布了新的文献求助10
4秒前
xiaxi完成签到,获得积分10
6秒前
ding的应助被xielaoban采纳,获得10
6秒前
7秒前
荼蘼发布了新的文献求助10
7秒前
8秒前
朴实颤完成签到,获得积分10
8秒前
9秒前
9秒前
chuqing发布了新的文献求助10
9秒前
momo完成签到,获得积分10
9秒前
无私的迎松完成签到,获得积分10
11秒前
YYJ完成签到,获得积分10
11秒前
酷波er的应助被积极亦竹采纳,获得10
12秒前
BAEKHYUNLUCKY发布了新的文献求助10
14秒前
14秒前
14秒前
14秒前
尘_发布了新的文献求助10
15秒前
BernardGo发布了新的文献求助10
18秒前
荼蘼发布了新的文献求助10
18秒前
慈祥的丹寒完成签到 ,获得积分10
22秒前
22秒前
冯老三完成签到 ,获得积分10
23秒前
Maestro_S的应助被chuqing采纳,获得10
23秒前
howeVer完成签到 ,获得积分10
23秒前
槟洛完成签到,获得积分10
23秒前
月亮代表我的心完成签到,获得积分10
24秒前
黄大树完成签到,获得积分10
24秒前
高挑的伊完成签到,获得积分10
25秒前
正直的又柔完成签到,获得积分10
26秒前
丘比特的应助被老年学术废物采纳,获得10
26秒前
Long发布了新的文献求助10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241